Press Releases

Month Year

Month Year

Investor Alerts

Nov 10, 2021

Trevi Therapeutics Announces Third Quarter 2021 Financial Results and Business Update

Phase 2b/3 PRISM (Chronic Pruritus in PN) Trial Approximately 90% Enrolled, Top-Line Data Readout Expected First Half of 2022
Nov 9, 2021

Trevi Therapeutics to Present at Stifel 2021 Virtual Healthcare Conference
Nov 3, 2021

Trevi Therapeutics to Report Q3 2021 Financial Results and Provide a Corporate Update on Wednesday, November 10, 2021

Conference Call and Webcast to be Held at 4:30 p.m. ET
Oct 13, 2021

Trevi Therapeutics to Present at 11th World Congress on Itch (WCI)
Oct 7, 2021

Trevi Therapeutics Participating in Alliance Global Partners' Virtual Biotech & Specialty Pharma Conference

Show per page

Media Contact

Katie Barrett
(203) 903-9627
k.barrett@trevitherapeutics.com

Trevi Therapeutics
195 Church Street, 16th Floor
New Haven, CT 06510
map